Magazine

Specialized publication dedicated to Good Manufacturing Practice, modernization of pharmaceutical production, and modern pharmaceutical manufacturing technologies

TOP News

Vialek Book Banner

Halo Labs to Acquire Bophelo Bioscience

Halo Labs Inc. announced that it has entered into a non-binding letter of intent (LOI) for the proposed acquisition of Bophelo Bioscience & Wellness (Pty) Ltd. The Transaction is expected to st...

FDA Approved Novo Nordisk’s Victoza

The U.S. Food and Drug Administration approved Victoza (liraglutide) injection for treatment of pediatric patients 10 years or older with type 2 diabetes. Victoza is the first non-insulin drug approve...

EC Approved Lynparza as 1st-Line Maintenance Treatment for BRCA-Mutated Ovarian Cancer

astrazeneca
AstraZeneca and MSD Inc., Kenilworth, N.J., US (MSD: known as Merck & Co., Inc. inside the US and Canada) announced that the European Commission (EC) has approved Lynparza (olaparib) as a 1st-line...

Abbott Launched Test To Detect Diabetes

blood-sugar
Abbott announced that its Afinion™ HbA1c Dx assay is now available for use on the Afinion 2 Analyzer, as well as the Afinion AS100 Analyzer. The Afinion HbA1c Dx assay is the first and only rapid poin...

BLINCYTO Five-Year Overall Survival Data Presented by Amgen

Amgen announced the five-year overall survival (OS) analysis from the single-arm, Phase 2 BLAST study that evaluated BLINCYTO® (blinatumomab) in patients with minimal residual disease (MRD)-positive a...

Pfizer to Acquire Biopharmaceutical Company Array BioPharma

Pfizer Inc. and Array BioPharma Inc. announced that they have entered into a definitive merger agreement under which Pfizer will acquire Array, a commercial stage biopharmaceutical company focused on ...

Sandoz Announced Data from Phase III ADMYRA Trial of Bosimilar Hyrimoz

biosimilars
Sandoz, a Novartis division and a global leader in biosimilars, announced data from the Phase III ADMYRA trial demonstrating that the efficacy and safety of biosimilar Hyrimoz® (adalimumab) matches th...

Subscribe to GMP news Newsletter!

Interview

SID&GP about MoU and Relatioship with UK

On January 29, the UK and Russia have signed a memorandum of understanding enhancing cooperation in the field of regulation of medicines. Radio Sputnik discussed the development with Nikolay Tsatsy...

InterPharm Technology Group®. Exceeding the expectations over 20 years

For 20 years, InterPharmTechnology Group® holds a prominent position in the market of pharmaceutical technological equipment in Russia and other EAEU member states.

Dara Pharma: Modern Pharmaceutical Equipment from Spain

David Rarl
One of the key factors that ensure that the manufacturers of drugs comply with GMP standards, is the implementation of modern technological equipment in their production plants which will be subsequen...

Counterfeit products will even not get into the licensed pharmacy chains

murashko
Russian State Duma adopted a bill on labeling of medicinal products with Data Matrix labels. This procedure will become mandatory from January 1, 2020

Subscribe to GMP news Newsletter!

Magazine

Specialized publication dedicated to Good Manufacturing Practice, modernization of pharmaceutical production, and modern pharmaceutical manufacturing technologies